AIA Hong Kong and Macau has announced a strategic partnership with Concord Healthcare, a leading healthcare group in Mainland China, to provide more affordable cancer care options for employees. This collaboration, effective from 11 September 2025, allows eligible insured members of AIA’s designated group insurance plans to access discounted cancer proton therapy and health screening packages at Guangzhou Concord Cancer Centre, a flagship institution known for its advanced cancer treatment capabilities.
Cancer remains a significant health challenge in Hong Kong, with a new diagnosis occurring every 15 minutes. This partnership aims to address the need for accessible and affordable cancer treatment, particularly as proton therapy, a precise and non-invasive treatment, can be costly in Hong Kong. By offering these services at preferential rates, AIA seeks to alleviate financial stress for employees and improve health outcomes.
Amelie Shen, Chief Corporate Solutions Officer of AIA Hong Kong and Macau, stated, “At AIA, we go beyond traditional employee benefits by delivering holistic and innovative solutions that support Hong Kong’s workforce and their families. This partnership is more than a healthcare solution—it represents our commitment to helping organisations and their employees access more affordable advanced cancer care when they need it most.”
This initiative is part of AIA’s broader vision to create a proactive, integrated wellness ecosystem that supports prevention, resilience, and recovery for employees and their families. By leveraging this collaboration, AIA aims to help employers build more resilient and healthier workforces, enabling employees and their families to live healthier, longer, and better lives.
